High-Energy Shockwaves and Extracorporeal High-Intensity Focused Ultrasound

Journal of Endourology

Volumn 17, Issue 8, 2003, Pages 667-672

  Madersbacher, Stephan ^a,b   Marberger, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL MODEL; BRAIN TISSUE; CLINICAL EXAMINATION; CLINICAL TRIAL; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENERGY; HUMAN; LITHOTRIPSY; METHODOLOGY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; RADIATION; REVIEW; SIGNAL TRANSDUCTION; ULTRASOUND THERAPY; UROGENITAL TRACT DISEASE;

EID: 0242330284     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/089277903322518680     Document Type: Review

References (64)

1. Madersbacher S, Marberger M. Therapeutic applications of ultrasound in urology. In: Marberger M (ed): Application of Newer Forms of Therapeutic Energy in Urology. Oxford, UK: ISIS Medical Media, 1995, pp 115-136.
2. Barnett SB, Ter Haar GR, Ziskin MC, Nyborg WL, Maeda K, Bang J. Current status of research on biophysical effects of ultrasound. Ultrasound Med Biol 1994;20:205-218.
3. Vallancien G, Chartier-Kastler E, Chopin D, Veillon B, Brisset JM, Andre-Bougaran J. Focused extracorporeal pyrotherapy: Experimental results. Eur Urol 1991;20:211-219.
4. Vallancien G, Harouni M, Veillon B, Mombet A, Prapotnich D, Brisset JM, Bougaran J. Focused extracorporeal pyrotherapy: Feasibility study in man. J Endourol 1992;6:173-181.
5. Chartier-Kastler E, Chopin D, Vallancien G. The effects of focused extracorporeal pyrotherapy on a human bladder tumor line (647V). J Urol 1993;149:643-647.
6. Vallancien G, Harouni M, Giullonneau B, Veillon B, Bougaran J. Ablation of superficial bladder tumors with focused extracorporeal pyrotherapy. Urology 1996;47:204-207.
7. Cornel EB, Oosterwijk E, van de Streek JD, Grutters G, Debruyne FM, Schalken JA, Oosterhof GO. High energy shock waves induced increase in the local cocentration of systemically given TNF-alpha. J Urol 1994;152:2164-2166.
8. Oosterhof GO Smits GA, de Ruyter AE, Schalken JA, Debruyne FM. Effects of high-energy shock waves combined with biological response modifiers in different human kidney cancer xenografts. Ultrasound Med Biol 1991;17:391-399.
9. Oosterhof GON, Smits GAH, de Ruyter AN. In vivo effect of high energy shock waves on urological tumors: An evaluation of treatment modalities. J Urol 1990;144:785-798.
10. Darzi A, Goldin R, Guillou PJ, Monson JR. High-energy shock waves pyrotherapy: A new concept in extracorporeal tumor therapy. Surg Oncol 1993;2:197-203.
11. Fickweiler S, Steinbach P, Worle K, Hofstadter F. The combined effects of high-energy shock waves and ionising radiation on a human bladder cancer cell line. Ultrasound Med Biol 1996;22:1097-1102.
12. Roessler W, Rothgangel B, Hofstadter F, Wieland WF. Treatment of human renal cell carcinoma with high-energy shock waves: A new in vivo/in vitro model. Urol Int 1995;55:1-5.
13. Worle K, Steinbach P, Hofstadter F. The combined effects of high-energy shock waves and cytostatic drugs or cytokines on human bladder cancer cells. Br J Cancer 1994;69:58-65.
14. Maruyama M, Asano T, Nakagohri T, Uematsu T, Hasegawa M, Miyauchi H, Iwashita C, Isono K. Application of high energy shock waves to cancer treatment in combination with cisplatin and ATX-70. Anticancer Res 1999;19:1989-1993.
15. Hoshi S, Orikasa S, Kuwahara M, et al. High energy underwater shock wave treatment on implanted urinary bladder cancer in rabbits. J Urol 1991;146:439-443.
16. Van Dongen JW, van Steenbrugge GJ, Romijn JC, Schroder FH. The cytocidal effect of high energy shock waves on human prostatic tumour cell lines. Eur J Cancer Clin Oncol 1989;25:1173-1179.
17. Fry FJ. Intense focused ultrasound in medicine. Eur Urol 1993;23(suppl 1):2-7.
18. Fry WJ, Barnard JW, Fry FJ, Krumins RF, Brennan JF. Ultrasonic lesions in the mammalian central nervous system. Science 1955;122:517-518.
19. Meyers R, Fry WJ, Fry FJ, Dreyer LL, Schultz DF, Meyer RF. Early experiences with ultrasonic irradiation of the pallidofugal and nigral complexes in hyperkinetic and hypertonic disorders. J Neurosurg 1959;16:32-54.
20. Linke CA, Carstensen EL, Frizzell LA, Elbadawi A, Fridd CW. Localized tissue destruction by high-intensity focused ultrasound. Arch Surg 1973;107:887-891.
21. Köhrmann KU, Back W, Kahmann F, Michel MS, Rassweiler J, Alken P. Morphological aspect of tissue lesions induced by focused ultrasound on different organs [abstract]. J Urol 1995;153:534A.
22. Ioritani N, Sirai S, Taguchi K, Orikasa S, Aida S, Fujimoto K, Kuwahara M. Effects of high intensity ultrasound heating on the normal and cancer tissue. Jap J Endourol ESWL 1994;7:299.
23. Hill CR, Rivens I, Vaughan MG, Ter Haar GT. Lesion development in focused ultrasound surgery: A general model. Ultrasound Med Biol 1994;20:259-269.
24. Ter Haar G. Focused ultrasound therapy. Curr Opin Urol 1994;4:89-92.
25. Ter Haar G, Sinnett D, Rivens I. High intensity focused ultrasound: A surgical technique for the treatment of discrete liver tumors. Phys Med Biol 1989;34:1743-1750.
26. Silvermann RH, Vogelsang B, Rondeau MJ, Coleman DJ. Therapeutic ultrasound for the treatment of glaucoma. Am J Ophthalmol 1991;111:327-337.
27. Lizzi FL. High-precision thermotherapy for small lesions. Eur Urol 1993;23(suppl 1):23-28.
28. Yang R, Sanghvi NT, Rescorla FJ, Galliani CA, Fry FJ, Griffith SI, Grosfeld JL. Extracorporeal liver ablation using sonography-guided high-intensity focused ultrasound. Invest Radiol 1992;27:796-803.
29. Chapelon JY, Margonari J, Theillere Y, Gorry F, Vernier F, Blanc E, Gelet A. Effects of high-energy focused ultrasound on kidney tissue in the rat and the dog. Eur Urol 1992;22:147-152.
30. Rutzen AR, Roberts CW, Driller J, Gomez D, Lucas BC, Lizzi FL, Coleman DJ. Production of corneal lesions using high-intensity focused ultrasound. Cornea 1990;9:324-330.
31. Chen L, Rivens I, Ter Haar GR, Riddler S, Hill CR, Bensted JPM. Histological changes in rat liver tumours treated with high intensity focused ultrasound. Ultrasound Med Biol 1993;19:67-74.
32. Hynynen K. The threshold for thermally significant cavitation in dog's thigh muscle in vivo. Ultrasound Med Biol 1991;17:157-169.
33. Vaez S, Fujimoto VY, Walker C, Martin RW, Chi EY, Crum LA. Treatment of uterine fibroid tumors in a nude mouse model using high-intensity focused ultrasound. Am J Obstet Gynecol 2000;183:6-11.
34. Yang R, Sanghvi NT, Rescorla FJ, Kopecky KK, Grosfeld JL. Liver cancer ablation with extracorporeal high-intensity focused ultrasound. Eur Urol 1993;23(suppl 1):17-22.
35. Sibille A, Prat F, Chapelon JY, El Fadil FA, Henry L, Theilliere Y, Ponchon T, Cathignol D. Characterization of extracorporeal ablation of normal and tumour-bearing liver tissue by high intensity focused ultrasound. Ultrasound Med Biol 1993;19:803-813.
36. Chapelon JY, Margonari J, Vernier F, Gorry F, Ecochard R, Gelet A. In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327. Cancer Res 1992;52:6353-6357.
37. Watkin NA, Morris SB, Rivens IH, Woodhouse CR, ter Haar GR. A feasibility study for the non-invasive treatment of superficial bladder tumours with focused ultrasound. Br J Urol 1996;78:715-721.
38. Watkin NA, Morris SB, Rivens IH, ter Haar GR. High-intensity focused ultrasound ablation of the kidney in a larger animal model. J Endourol 1997;11:191-196.
39. Adams JB, Moore RG, Anderson JH, Strandberg JD, Marshall FF, Kavoussi LR. High-intensity focused ultrasound ablation of rabbit kidney tumors. J Endourol 1996;10:71-75.
40. Madersbacher S, Kratzik C, Susani M, Marberger M. Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. J Urol 1994;152:1956-1961.
41. Madersbacher S, Pedevilla M, Vingers L, Susani M, Marberger M. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 1995;55:3346-3351.
42. Kishi M, Mishima T, Itakura T. Experimental studies of effects of intense ultrasound on implantable murine glioma. In: Kazner E, de Vlieger M, Muller HR, McCready VR (eds): Proc 2nd Eur Congr Ultrasonics Med. Amsterdam: Excerpta Medica, 1975, pp 28-33.
43. Fry FJ, Johnson LK. Tumor irradiation with intense ultrasound. Ultrasound Med Biol 1978;4:337-341.
44. Moore WE, Lopez RM, Matthews DE, et al. Evaluation of high-intensity therapeutic ultrasound irradiation in the treatment of experimental hepatoma. J Pediatr Surg 1989;24:30-33.
45. Osterhof GO, Cornel EB, Smith GA, Debruyne FM, Schalken JA. Influence of high-intensity focused ultrasound on the development of metastases. Eur Urol 1997;32:91-95.
46. Sanghvi NT, Foster RS, Bihrle R, et al. Noninvasive surgery of prostate tissue by high intensity focused ultrasound: An updated report. Eur J Ultrasound 1999;9:19-29.
47. Bihrle R, Foster RS, Sanghvi NT, Donohue JP, Hood PJ. High intensity focused ultrasound for the treatment of BPH: Early U.S. clinical experience. J Urol 1994;151:1271-1275.
48. Gelet A, Chapelon JY, Bouvier R, Pangaud C, Lasne Y. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: Preliminary results. J Urol 1999;161:156-162.
49. Gelet A, Chapelon JY, Bouvier R, Rouviere O, Lyonnet D, Dubernard JM. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: Factors influencing outcome. Eur Urol 2001;40:124-129.
50. Madersbacher S, Gröbl M, Kramer G, Dimhofer S, Steiner GE, Marberger M. Regulation of heat shock protein 27 expression of prostatic cells in response to heat treatment. Prostate 1998;37:174-181.
51. Beerlage HP, van Leenders GJ, Oosterhof GO, Witjes JA, Ruijter ET, van de Kaa CA, Debruyne FM, Rosette JJMCH de la. High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical prostatectomy: Results of a prospective study. Prostate 1999;39:41-46.
52. Beerlage HP, Thüroff S, Debruyne FM, Chaussy C, Rosette JJMCH de la. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate cancer. Urology 1999;54:273-277.
53. Thüroff S, Chaussy C. Therapy of localized prostate cancer with high intensity focused ultrasound: Results and side effects. Urologe A 2001;40:191-194.
54. Madersbacher S, Kratzik C, Susani M, Pedevilla M, Marberger M. Transcutaneous high-intensity focused ultrasound and irradiation: An organ-preserving treatment of cancer in a solitary testis. Eur Urol 1998;33:195-201.
55. Susani M, Madersbacher S, Kratzik C, Vingers L, Marberger M. Morphology of tissue destruction induced by focused ultrasound. Eur Urol 1993;23 (suppl 1):34-38.
56. Chauhan S, Lowe MJ, Davies BL. A multiple focused probe approach for high intensity focused ultrasound based surgery. Ultrasonics 2001;39:33-44.
57. Foldes K, Hynynen K, Shortkroff S, Winalski CS, Collucci V, Koskinen SK, McDannold N, Jolesz F. Magnetic resonance imaging-guided focused ultrasound synovectomy. Scand J Rheumatol 1999;28:233-237.
58. Sokka SD, Hynynen KH. The feasibility of MRI-guided whole prostate ablation with a linear aperiodic intracavitary ultrasound phased array. Phys Med Biol 2000;45:3373-3383.
59. Prat F, Chapelon JY, Arefiev A, Cathignol D, Souchon R, Theilliere Y. High-intensity focused ultrasound transducers suitable for endoscopy: Feasibility study in rabbits. Gastrointest Endosc 1997;46:348-351.
60. Smith NB, Hynynen K. The feasibility of using focused ultrasound for transmyocardial revascularization. Ultrasound Med Biol 1998;24:1045-1054.
61. Lee LA, Simon C, Bove EL, Mosca RS, Ebbini ES, Abrams GD, Ludomirsky A. High intensity focused ultrasound effect on cardiac tissues: Potential for clinical application. Echocardiography 2000;17:563-566.
62. Strickberger SA, Tokano T, Kluiwstra JUA, Morady F, Cain C. Extracardiac ablation of the canine atrioventricular junction by use of high-intensity focused ultrasound. Circulation 1999;100:203-208.
63. Vaez S, Marti R, Mourad P, Crum L. Hemostasis using high intensity focused ultrasound. Eur J Ultrasound 1999;9:79-87.
64. Huber PE, Pfisterer P. In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound. Gene Ther 2000;7:1516-1526.